MARKSANSPharmaceuticals
Marksans Pharma Ltd — PE Ratio & Valuation Analysis
₹156.89
-1.28%
Current P/E25.09xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E25.6x2.0% below avg
✅
21.0% Discount to Industry
MARKSANS P/E 25.09x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹8.40 | ₹180 | 21.5x |
| 2024 | ₹6.92 | ₹297 | 42.9x |
| 2023 | ₹6.41 | ₹161 | 25.1x |
| 2022 | ₹4.51 | ₹58 | 12.9x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Marksans Pharma Ltd Valuation
Marksans Pharma Ltd (MARKSANS) currently trades at 25.09x earnings. The Pharmaceuticals sector average PE is 31.77x. MARKSANS is trading at a discount to peers — may indicate relative value. Historically, MARKSANS has traded at an average PE of 25.6x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
16.77%
Dividend Yield
0.41%
More on Marksans Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.